TLX Earnings

TLX reported its earnings on 2025-08-20, showcasing a revenue of 204.00M against an estimate of 204.28M, resulting in a -0.14% surprise. The EPS was 0.18, surpassing the expected 0.12 by 53.42%. The stock experienced a 10.21% price change on the earnings day and a 14.31% change over the next five days, reflecting market reactions to the results.

Following TLX's earnings announcement on 2025-08-20, the stock price moved by 10.21% on the day of the release. Over the subsequent five days, it saw a 14.31% change. Historically, TLX's stock price tends to shift by an average of 9.12% in the 10 days leading up to earnings and -17.23% in the 10 days following, providing insight into potential market.

For , analysts estimate TLX's annual revenue to reach undefined, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised upward by 0.43% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between TLX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.43%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TLX's stock price typically moves by 9.12% in the 10 days before its earnings and -17.23% in the 10 days after. For the upcoming earnings, analysts expect an EPS of undefined and revenue of undefined.

The earnings call reveals positive financial performance with strong operating cash flow and EBITDA. The Q&A section indicates strategic growth plans, especially in precision medicine, and proactive R&D investments. Despite some uncertainties in FDA timelines, the overall sentiment is optimistic due to strategic initiatives and expected revenue growth. The market reaction is likely to be positive, supported by the company's focus on expanding international markets and improving gross margins.